ZA200804027B - Neuroendocrine tumor treatment using m TOR inhibitors - Google Patents

Neuroendocrine tumor treatment using m TOR inhibitors

Info

Publication number
ZA200804027B
ZA200804027B ZA200804027A ZA200804027A ZA200804027B ZA 200804027 B ZA200804027 B ZA 200804027B ZA 200804027 A ZA200804027 A ZA 200804027A ZA 200804027 A ZA200804027 A ZA 200804027A ZA 200804027 B ZA200804027 B ZA 200804027B
Authority
ZA
South Africa
Prior art keywords
tumor treatment
neuroendocrine tumor
tor inhibitors
tor
inhibitors
Prior art date
Application number
ZA200804027A
Inventor
Marks Peter Wayne
Lebwohl David
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35580407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200804027(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200804027B publication Critical patent/ZA200804027B/en

Links

ZA200804027A 2005-11-21 2008-05-12 Neuroendocrine tumor treatment using m TOR inhibitors ZA200804027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0523658A GB0523658D0 (en) 2005-11-21 2005-11-21 Organic compounds

Publications (1)

Publication Number Publication Date
ZA200804027B true ZA200804027B (en) 2009-03-25

Family

ID=35580407

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804027A ZA200804027B (en) 2005-11-21 2008-05-12 Neuroendocrine tumor treatment using m TOR inhibitors

Country Status (3)

Country Link
CN (1) CN101360496B (en)
GB (1) GB0523658D0 (en)
ZA (1) ZA200804027B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110755438A (en) * 2019-11-22 2020-02-07 昆明医科大学 Application of levofloxacin antibiotic in preparing anti-cancer drug sensitizing drug and anti-cancer drug thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2442849A1 (en) * 2001-04-06 2002-10-17 Wyeth Antineoplastic combinations such as rapamycin together with gemcitabine or fluorouracil
CA2447732A1 (en) * 2001-06-01 2002-12-12 Wyeth Antineoplastic combinations
EP1720574A4 (en) * 2004-02-23 2009-09-09 Sugen Inc Method of treating abnormal cell growth using c-met and-tor inhibitors

Also Published As

Publication number Publication date
GB0523658D0 (en) 2005-12-28
CN101360496B (en) 2015-02-25
CN101360496A (en) 2009-02-04

Similar Documents

Publication Publication Date Title
IL253698A0 (en) Neuroendocrine tumor treatment using mtor inhibitors
ZA200805877B (en) Pyridiazinone derivatives for tumour treatment
IL179398A0 (en) Dpp-ib inhibitors
IL183889A0 (en) Treatment method
IL188430A0 (en) Treatment of tumors
IL186408A0 (en) Combination treatment methods
EP1755394A4 (en) Cancer treatment method
ZA200705059B (en) Cancer treatment method
PT1830847E (en) Treatment for cancer
IL179323A0 (en) Cancer treatment method
GB2430002B (en) Well treatment
IL179359A0 (en) Cancer treatment method
IL184330A0 (en) Treatment apparatus
EP2088862A4 (en) Cancer treatment method
GB0428187D0 (en) Cancer treatment
GB0421355D0 (en) Inhibitors
GB0413346D0 (en) Treating cancer
EP1802617A4 (en) Cancer treatment method
GB0525535D0 (en) Tumour treatment
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
ZA200804027B (en) Neuroendocrine tumor treatment using m TOR inhibitors
GB0421356D0 (en) Inhibitors
GB0507685D0 (en) Cancer treatment
GB0404675D0 (en) Cancer treatment